Keyphrases
Low Expression
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Early Breast Cancer
100%
Hormone Receptor-positive
100%
Prognostic Impact
100%
Genomic Risk
25%
Overall Survival
12%
Recurrence Risk
12%
Long-term Prognosis
12%
Disease-free Survival
12%
Estrogen Receptor-positive
12%
Distant Metastasis-free Survival
12%
Recurrence Score
12%
Oncotype DX
12%
Breast Cancer
6%
Disease Pattern
6%
Immunohistochemistry
6%
Favorable Outcome
6%
In Situ Hybridization
6%
Distinct Entity
6%
Pathological Characteristics
6%
Disease Outcome
6%
Pathological Features
6%
Single-center Retrospective Study
6%
Human Epidermal Growth Factor Receptor 2-negative
6%
Luminal Disease
6%
Medicine and Dentistry
Breast Cancer
100%
Epidermal Growth Factor Receptor 2
100%
Hormone Receptor
100%
Gamma Urogastrone
100%
Disease
23%
Disease Free Survival
23%
Overall Survival
11%
Recurrence Risk
11%
Estrogen Receptor
11%
Prevalence
5%
Recurrent Disease
5%
Immunohistochemistry
5%
Retrospective Study
5%
in Situ Hybridization
5%
Oncotype DX
5%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Hormone Receptor
100%
Disease Free Survival
23%
Estrogen Receptor
11%
Overall Survival
11%
Prevalence
5%
Retrospective Study
5%
in Situ Hybridization
5%